SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001213900-20-006563
Filing Date
2020-03-16
Accepted
2020-03-16 17:41:25
Documents
1
Period of Report
2020-03-09

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 3006
  Complete submission text file 0001213900-20-006563.txt   4385
Mailing Address 15 SKYLINE DRIVE HAWTHORNE NY 10532
Business Address
Wessel Thomas (Reporting) CIK: 0001456055 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39082 | Film No.: 20718467

Mailing Address 880 3RD AVENUE, 12TH FLOOR NEW YORK NY 10022
Business Address 880 3RD AVENUE, 12TH FLOOR NEW YORK NY 10022 646 876 3459
RELMADA THERAPEUTICS, INC. (Issuer) CIK: 0001553643 (see all company filings)

IRS No.: 455401931 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations